Unlocking the Potential of Biomanufacturing Investments

Demand is solidifying for products that use biological manufacturing processes. But for change to happen, biomanufacturing costs must lower. Experts at SynBioBeta explore what it will take to enable bioproducts to compete with low-margin, high volume products from petrochemicals.

Synonym Finance raises $1.5 million in a seed round led by Borderless Capital to revolutionize cross-chain lending and tackle fragmented markets. Synonym, a biomanufacturing infrastructure company, is unlocking the market forces to enable a quickly-maturing multi-hundred billion dollar sector.

Primient, established in 2022 when Tate & Lyle sold a controlling stake in its Primary products business to KPS Capital Partners, is making waves in the investment world. A one-stop shop is a business that offers a multitude of products or services to its customers, all under one roof.

If you love stories about beautiful losers, consider Brian Moore's novel about an alcoholic virgin or Benjamin Anastas's tale of an inferior product. How illogic in DOL's Retirement Security Rule produces a crisis of identity for insurance professionals.

As high interest rates and fears of an economic slowdown make investors reluctant to finance expensive projects, companies will have to find new ways to attract capital. Synonym Finance's successful seed round is a sign of changing times in the investment landscape.